CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kyowa Kirin Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kyowa Kirin Co Ltd
Otemachi Financial City Grand Cube
1-9-2, Ote-machi
Phone: +81 352057200p:+81 352057200 CHIYODA-KU, TKY  100-0004  Japan Ticker: 41514151

This company was Merged or Acquired on 4/1/2008.
This is a Subsidiary, click here for the Parent Company

Business Summary
Kyowa Kirin Co Ltd, formerly Kyowa Hakko Kirin Co Ltd is a Japan-based company engaged in the manufacture and sale of prescription pharmaceuticals. The Company operates in a single pharmaceuticals business segment. The Company engages in the research, development, manufacture, sale, and import & export of prescription pharmaceuticals. The Company has POTELLIGENT technology for producing active antibodies. The Company provides products include Poteligeo for the treatment of mycosis fungoides and sezary syndrome, and Crysvita for the treatment of X chromosome-linked hypophosphatemia. Besides, the Company also develops, manufactures, and markets biosimilar drugs, and engages in contracting, wholesale and retail business, and insurance agency business. The Company operates in Japan and overseas.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023Yes---Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer, Executive Officer, Representative Director MasashiMiyamoto 64 3/1/2019 3/22/2012
Managing Executive Officer, Chief Financial Officer MotohikoKawaguchi 4/1/2024 3/1/2018
Vice President, Chief Compliance Officer, Representative Director YutakaOsawa 64 4/1/2024 3/22/2013
12 additional Officers and Directors records available in full report.

Business Names
Business Name
4151
KY4
KYKOY
10 additional Business Names available in full report.

General Information
Number of Employees: 5,974 (As of 12/31/2023)
Outstanding Shares: 537,609,288 (As of 12/31/2023)
Shareholders: 34,384
Stock Exchange: TYO
Fax Number: +81 352057182


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024